SUPPORTED BY :
MEDIA PARTNER :
ORGANIZED BY
 
 
 
   
Kenya is currently the largest producer of pharmaceutical products in the Common Market for Eastern and Southern Africa (COMESA) region, supplying about 50% of the regions’ market. Out of the region’s estimated of 50 recognized pharmaceutical manufacturers; approximately 30 are based in Kenya
   
Kenya's pharmaceutical industry is on a rebound, riding on the back of increased expenditure in healthcare and general economic growth over the years
   
The rapid growth of the pharmaceutical market in the region has presented the need to increase quantity of production, and also increase the export ratio for quality products. Kenya is currently the largest producer of pharmaceutical products in the Common Market for Eastern and Southern Africa (COMESA) region, supplying about 50 percent of the region’s market
   
The country’s pharmaceutical and consumer health market is estimated to be worth an estimated USD 160 million each year
 
Sales of over-the-counter (OTC) and prescription drugs clocked up sales of 17.7 billion Kenyan shillings (USD 234.6 million) in 2008, up 22.9% from Sh14.4 billion the previous year, according to the Kenya Pharmaceutical and Health Report 2010
 
By 2014, the Kenyan drug market is expected to hit a value of Sh33.5 billion, equating to a compound annual growth rate (CAGR) of 13.53% in local currency terms and 22.8% in US dollar terms
 
The pharmaceutical sector consists of more than 35 licensed units include local manufacturing companies and large Multi National Corporations (MNCs), subsidiaries or joint ventures. Most are located within Nairobi and its environs. These firms collectively employ over 2,000 people, about 65% of who work in direct production
 
The industry compounds and packages medicines, repacking formulated drugs and processing bulk drugs into doses using predominantly imported active ingredients and excipients. The bulk of locally manufactured preparations are non-sterile, over-the-counter (OTC) products
 
The number of companies engaged in manufacturing and distribution of pharmaceutical products in Kenya continue to expand, driven by the Government’s efforts to promote local and foreign investment in the sector
 
Kenya enjoys preferential access to the regional market under a number of special access and duty reduction programmes related to the East African Community (EAC) and the Common Market for Eastern and Southern Africa (COMESA) among others
 
The country exports its medicinal and pharmaceutical products to Tanzania, Uganda, DRC, Rwanda, Burundi, the Comoros, Ethiopia and Malawi among other destinations
 
The value of Kenyan medicinal and pharmaceutical products exported increased from KShs 1.6 billion in 1999 to 2.1 billion in 2003
 
 
 
All rights are reserved to Kenya Pharma Expo